Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
collaboration with research groups at CSHL and at external partner organizations. Developing and publishing innovative approaches for proteomic and metabolomic analyses is a core mission of the lab
-
areas of biology to uncover new principles governing health and disease. We will consider a broad range of early-career researchers holding a PhD and/or MD for this position. CSHL is a world-renowned
-
hematopoietic malignancies and develop novel therapeutic strategies. Position Responsibilities The Lab utilizes a combination of CRISPR/Cas functional genomics and metabolomics as well as optogenetics and fiber
-
educational institution located on the North Shore of Long Island, New York. The highly ranked School of Biological Sciences at CSHL trains PhD students, including through a recently launched BioAI PhD program
-
an prep · Conduct teacher training and · Present public tours · Conducting teacher training and developing teaching modules. Position Requirements EDUCATION: · Bachelor’s degree with significant coursework
-
environment. In addition to ensuring outstanding day-to-day operations, the Director will be expected to develop and execute a forward-looking vision for the future growth of the Histology Core, including
-
discovery and chemical biology. Our lab is working to understand the molecular mechanisms leading to efficient elicitation of tumor vulnerability for potent cancer targeting. We develop Targeted Protein
-
partnership with our clinical collaborators to develop highly effective cancer immunotherapy modalities with minimal toxicity to host. Position Requirements Education: PhD in biomedical sciences, ideally in
-
preparing materials for Compensation Review and Advisory Committee (CR & AC) meetings, preparing Board of Trustees materials, and coordinating document distribution. Prepare reports, correspondence, and
-
research project focused on mechanistic dissection of a neurodevelopmental genetic disorder and preclinical development of antisense oligonucleotide (ASO) therapeutics. The successful candidate will lead and